Market Tracker

05/24 3:40am ET

Shire PLC (NASDAQ:SHPG)

186.16
Delayed Data
As of May 23
 +0.46 / +0.25%
Today’s Change
147.60
Today|||52-Week Range
270.63
-9.19%
Year-to-Date
CF Industries Pulls $8B Takeover of OCI Assets
May 23 / TheStreet.com - Paid Partner Content
Immune Design (IMDZ) Loss Narrower than Expected in Q1
May 11 / Zacks.com - Paid Partner Content
British CEOs should take a 50% pay cut
May 20 / CNNMoney.com
Epizyme (EPZM) Reports Narrower-than-Expected Q1 Loss
May 10 / Zacks.com - Paid Partner Content
Today's Pre-Market Trading Very Positive For Shire (SHPG)
May 19 / TheStreet.com - Paid Partner Content
Why Amicus Therapeutics, Inc. Stock Slumped 14.0% in April
May 10 / MotleyFool.com - Paid Partner Content
5 Foreign Stocks Worth Investing Post-Q1 Earnings
May 17 / Zacks.com - Paid Partner Content
Is this CEO worth 1,444 times what he pays his employees?
Apr 29 / CNNMoney.com
Catalyst (CPRX) Posts In-Line Q1 Loss, Firdapse in Focus
May 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close185.70
Today’s open186.79
Day’s range185.16 - 188.98
Volume3,736,110
Average volume (3 months)2,435,402
Market cap$36.7B
Dividend yield0.73%
Data as of 4:00pm ET, 05/23/2016

Growth & Valuation

Earnings growth (last year)-61.89%
Earnings growth (this year)+9.61%
Earnings growth (next 5 years)+12.85%
Revenue growth (last year)+6.79%
P/E ratio27.6
Price/Sales6.33
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-0.01-0.01%
ZTSZoetis Inc-0.66-1.40%
MYLMylan NV-0.30-0.72%
VRTXVertex Pharmaceutica...-0.28-0.33%
Data as of 4:02pm ET, 05/23/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$3.09
Annual revenue (last year)$6.4B
Annual profit (last year)$1.3B
Net profit margin20.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts